From depot to dose: the power of RTSM integration in temperature excursion management

Temperature excursions can occur at any stage of the clinical supply chain—from depot to site to patient—posing significant risks to product integrity, compliance, and trial timelines. In this session, experts from Endpoint Clinical and Berlinger will explore how real-time temperature monitoring and RTSM integration provide full visibility across the entire supply journey.

We’ll break down how shipment and site-level integration within an RTSM system minimizes human error, enhances decision-making, and reduces drug wastage. Attendees will gain actionable insights into how connected systems empower site staff, streamline operations, and drive efficiency across clinical trials.

Key Takeaways:

  • The impact of temperature excursions across the clinical supply chain
  • How integration enhances visibility and reduces manual effort
  • The role of real-time data in proactive excursion management
  • Measurable benefits in efficiency, compliance, and waste reduction

AI-powered innovation: transforming clinical supply chains and studies

  • Providing a clear understanding of Artificial Intelligence (AI) by exploring its definition, key components, and how it simulates human intelligence
  • Highlighting the importance of AI in the clinical domain by discussing its impact on efficiency, accuracy, and innovation
  • Specific applications of AI in managing clinical supply chains. Topics will include AI’s role in demand forecasting, inventory optimization, and ensuring timely and efficient delivery of clinical materials
  • How AI enhances clinical studies by streamlining patient recruitment, analyzing trial data, and identifying patterns that improve outcomes
  • Addressing the challenges in adopting AI, such as data privacy concerns, integration issues, and the need for skilled expertise

Moving science forward in 2025: emerging trends in the life science logistics industry

  • With constantly shifting regulations, new technologies and sustainability concerns, the life science logistics sector continues to develop at a rapid pace. Biocair’s position as a leading global life sciences logistics expert at the forefront of industry excellence and customer service means the company has a unique insight into the future of this sector.
  • Sustainability is now a crucial consideration within supply chain dynamics. This is part of a broader industry trend of companies collectively committing to sustainability targets.
  • With a decrease in funding being observed throughout 2024, collaboration is now more than ever a top priority.
  • As advances in treatments drive a shift towards personalized medicines, adherence to regulatory standards becomes paramount to ensure that sensitive and critical life science materials can be delivered to patients with the highest of care
  • The impact of recent global events can still be felt throughout the world of supply chain logistics. What is clear now more than ever is the need to be agile and flexible within the rapidly moving industry, where next-generation treatments are necessitating new approaches to logistics